Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Holista Colltech Limited ( (AU:HCT) ).
Holista Colltech Limited has successfully received $1.53 million from Converting Notes and made a final payment of $900,000 to the Australian Securities and Investments Commission, fulfilling obligations under a Federal Court order. These financial developments signify a milestone in Holista’s strategy, emphasizing its commitment to financial stability and regulatory compliance, and allowing the company to focus on advancing its business operations.
More about Holista Colltech Limited
Holista Colltech Ltd is a research-driven biotech company formed from the merger of Holista Biotech Sdn Bhd and Colltech Australia Ltd. Listed on the Australian Securities Exchange, the company is headquartered in Perth and operates in multiple countries, including Malaysia and North America. Holista focuses on developing natural solutions for healthier living, providing proprietary solutions for food manufacturers to create healthier alternatives without chemicals, and has expertise in advanced collagen and nano-collagen technologies.
YTD Price Performance: 123.08%
Average Trading Volume: 270,041
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$8.29M
For detailed information about HCT stock, go to TipRanks’ Stock Analysis page.